Advisors Asset Management, Inc. Novo Cure LTD Transaction History

Advisors Asset Management, Inc.

$4.99 Billion
Q2 2024

A detailed history of Advisors Asset Management, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 949 shares of NVCR stock, worth $14,813. This represents 0.0% of its overall portfolio holdings.

Number of Shares

949

Previous 1,054 9.96%

Holding current value

$14,813

Previous $16,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $1,242 - $2,525	-105 Reduced 9.96%	949 $16,000
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $11,731 - $16,632	1,054 New	1,054 $15,000
Q1 2023 May 12, 2023	SELL	$56.44 - $118.81 $76,814 - $161,700	-1,361 Reduced 26.74%	3,729 $224,000
Q4 2022 Feb 13, 2023	SELL	$63.98 - $85.37 $524,827 - $700,290	-8,203 Reduced 61.71%	5,090 $373,000
Q3 2022 Nov 08, 2022	SELL	$67.99 - $89.57 $18,901 - $24,900	-278 Reduced 2.05%	13,293 $1.01 Million
Q2 2022 Aug 08, 2022	SELL	$56.6 - $89.9 $15,848 - $25,172	-280 Reduced 2.02%	13,571 $943,000
Q1 2022 May 17, 2022	SELL	$60.15 - $84.52 $761,799 - $1.07 Million	-12,665 Reduced 47.76%	13,851 $1.15 Million
Q4 2021 Feb 15, 2022	SELL	$75.08 - $121.99 $268,486 - $436,236	-3,576 Reduced 11.88%	26,516 $1.99 Million
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $693,999 - $1.16 Million	-5,974 Reduced 16.56%	30,092 $3.5 Million
Q2 2021 Jul 30, 2021	SELL	$130.4 - $225.58 $317,393 - $549,061	-2,434 Reduced 6.32%	36,066 $8 Million
Q1 2021 May 07, 2021	SELL	$124.11 - $190.17 $459,455 - $704,009	-3,702 Reduced 8.77%	38,500 $5.09 Million
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $93,204 - $144,710	-831 Reduced 1.93%	42,202 $7.3 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $658,228 - $1.26 Million	-11,339 Reduced 20.85%	43,033 $4.79 Million
Q2 2020 Aug 12, 2020	SELL	$57.2 - $74.41 $778,091 - $1.01 Million	-13,603 Reduced 20.01%	54,372 $3.22 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $111,989 - $187,957	1,963 Added 2.97%	67,975 $4.58 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $871,371 - $1.2 Million	-12,758 Reduced 16.2%	66,012 $6.24 Million
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $101,079 - $159,805	1,634 Added 2.12%	78,770 $5.89 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $215,955 - $323,421	5,115 Added 7.1%	77,136 $4.88 Million
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $420,593 - $738,539	13,160 Added 22.36%	72,021 $3.47 Million
Q4 2018 Jan 31, 2019	BUY	$28.72 - $52.63 $527,959 - $967,497	18,383 Added 45.41%	58,861 $1.97 Million
Q3 2018 Nov 15, 2018	BUY	$32.0 - $52.4 $922,400 - $1.51 Million	28,825 Added 247.36%	40,478 $2.12 Million
Q2 2018 Aug 22, 2018	SELL	$19.85 - $32.0 $70,229 - $113,216	-3,538 Reduced 23.29%	11,653 $365,000
Q2 2018 Aug 15, 2018	BUY	$19.85 - $32.0 $301,541 - $486,112	15,191 New	15,191 $365,000

Others Institutions Holding NVCR

# of Institutions

272

Shares Held

77.2M

Call Options Held

751K

Put Options Held

293K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.64B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Novo Cure LTD Transaction History